ReviewACS nano2023
Extra-Pulmonary Translocation of Exogenous Ambient Nanoparticles in the Human Body.
Review in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 28 citations in OpenAlex.
- Comments on "Coal Dust-Mimetic Carbon Nanoparticles Induce Colonic Epithelial Cell Senescence via p16/p21 Dual Pathways and Promote Colonic Inflammatory Response".Journal of gastroenterology and hepatology · 2026Article
- DNA damage in the leukocytes of nanocomposite-exposed workers.Mutagenesis · 2026Article
- Detection and Proinflammatory Effects of BTEX within the Human Atherosclerotic Plaque.Environmental science & technology · 2025Observational
- Enhanced Intrusion of Exogenous Airborne Fine Particles toward Eyes in Humans and Animals: Where Damaged Blood-Ocular Barrier Plays a Crucial Role.Environmental science & technology · 2024Article
- Airborne Aluminum as an Underestimated Source of Human Exposure: Quantification of Aluminum in 24 Human Tissue Types Reveals High Aluminum Concentrations in Lung and Hilar Lymph Node Tissues.Environmental science & technology · 2024Article
- Cancer cell membrane-camouflaged CuPt nanoalloy boosts chemotherapy of cisplatin prodrug to enhance anticancer effect and reverse cisplatin resistance of tumor.Materials today. Bio · 2024Article
- Micro- and nanoplastics (MNPs) and their potential toxicological outcomes: State of science, knowledge gaps and research needs.NanoImpact · 2023Review
- Cell Death Pathways: The Variable Mechanisms Underlying Fine Particulate Matter-Induced Cytotoxicity.ACS nanoscience Au · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As one of the major pollutants in the air, ambient fine particles are gaining considerable attention in terms of public health concerns. Significant progress has been achieved in recent years in understanding the biological effects and mechanisms of ambient fine particles. The airborne particles can enter the human body through various pathways and translocate to a range of different organs and further stay in these organs for extended periods. Current studies are making substantial achievements, while many challenges remain. On one hand, the whole picture of the concurrent exposure pathways and the translocation of particles in the human body should be explored, requiring technological advances and systematic biobanking of human samples for analysis. On the other hand, the correlation between the environmental exposure concentration of ambient particles and internal fate (i.e., dose, distribution patterns, and kinetics) of invasive particles needs to be investigated. Moreover, the biotransformation of particles in vivo should be considered, and more information is needed to differentiate exogenous particles from biological macromolecules and biogenically formed particles. We recapitulate the current knowledge gaps in understanding the fate of exogenous ambient fine particles in extra-pulmonary organs of the human body and the related biological effects and also propose future research directions to support both fundamental studies and policy making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.